Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB)

CUSIP: 45782T105

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
27,969,231
Total 13F shares
2,186,070
Share change
+381,683
Total reported value
$24,850,986
Put/Call ratio
93%
Price per share
$9.08
Number of holders
32
Value change
+$8,529,775
Number of buys
14
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 45782T105?
CUSIP 45782T105 identifies INMB - Inmune Bio, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) as of Q2 2023

As of 30 Jun 2023, Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) was held by 32 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,186,070 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., Janney Montgomery Scott LLC, MEITAV INVESTMENT HOUSE LTD, Rhenman & Partners Asset Management AB, GEODE CAPITAL MANAGEMENT, LLC, DEUTSCHE BANK AG\, Royal Bank of Canada, QUADRANT CAPITAL GROUP LLC, and MAI Capital Management. This page lists 33 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.